(Q71181831)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8678159%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

title

Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8678159%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference

J P Roberts

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8678159%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

J R Lurain

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8678159%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Obstetrics and Gynecology

16 October 2019

language of work or name

English

1 reference

inferred from

publication date

1 June 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8678159%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Obstetrics and Gynecology

16 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8678159%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

volume

174

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8678159%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8678159%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

page(s)

1917-23; discussion 1923-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8678159%20AND%20SRC:MED&resulttype=core&format=json

Effect of methotrexate therapy upon choriocarcinoma and chorioadenoma

16 October 2019

cites work

2 references

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970229-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970229-6

7 January 2021

Five year's experience with the chemotherapy of metastatic choriocarcinoma and related trophoblastic tumors in women

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970229-6

SEQUENTIAL USE OF METHOTREXATE AND ACTINOMYCIN D IN THE TREATMENT OF METASTATIC CHORIOCARCINOMA AND RELATED TROPHOBLASTIC DISEASES IN WOMEN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970229-6

Risk and prognostic factors in trophoblastic neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970229-6

Gestational trophoblastic disease. A comparative study of the results of therapy in patients with invasive mole and with choriocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970229-6

5-day methotrexate for women with metastatic gestational trophoblastic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970229-6

Actinomycin D as the primary agent for gestational trophoblastic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970229-6

Ten year's experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970229-6

Methotrexate with citrovorum factor rescue as primary therapy for gestational trophoblastic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970229-6

Use of oral VP16-213 as primary chemotherapeutic agent in treatment of gestational trophoblastic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970229-6

INFUSION THERAPY FOR PELVIC TROPHOBLASTIC TUMOURS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970229-6

Correlation of plasma methotrexate concentration with human chorionic gonadotropin and therapeutic response to low-dose methotrexate-citrovorum factor in low-medium-risk gestational trophoblastic tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970229-6

Metastatic gestational trophoblastic disease: A comparison of prognostic classification systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970229-6

Role of computed axial tomography of the chest in staging patients with nonmetastatic gestational trophoblastic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970229-6

Treatment of metastatic trophoblastic disease: good and poor prognosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970229-6

7 January 2021

Follow-up after hydatidiform mole: studies using radioimmunoassay for urinary human chorionic gonadotrophin (HCG).

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970229-6

7 January 2021

The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT).

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970229-6

7 January 2021

10.1016/S0002-9378(96)70229-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8678159%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference